PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsFORODESINE
FORODESINE
Forodesine is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against purine nucleoside phosphorylase.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
No data
Commercial
No data
Clinical
No data
Drug
General
Drug common nameFORODESINE
INNforodesine
Description
Forodesine (INN; also known as Immucillin H; trade names Mundesine and Fodosine) is a transition-state analog inhibitor of purine nucleoside phosphorylase studied for the treatment of patients with T-cell acute lymphoblastic leukemia (T-ALL) and for treatment of B-cell acute lymphocytic leukemia (B-ALL).
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
O=c1[nH]cnc2c([C@@H]3N[C@H](CO)[C@@H](O)[C@H]3O)c[nH]c12
Identifiers
PDB
CAS-ID209799-67-7
RxCUI
ChEMBL IDCHEMBL218291
ChEBI ID43362
PubChem CID444499
DrugBank
UNII ID426X066ELK (ChemIDplus, GSRS)
Target
Agency Approved
PNP
PNP
Organism
Homo sapiens
Gene name
PNP
Gene synonyms
NP
NCBI Gene ID
Protein name
purine nucleoside phosphorylase
Protein synonyms
epididymis secretory sperm binding protein Li 156an, HEL-S-156an, Inosine phosphorylase, Inosine-guanosine phosphorylase, purine-nucleoside:orthophosphate ribosyltransferase
Uniprot ID
Mouse ortholog
Pnp (18950)
purine nucleoside phosphorylase (P23492)
Alternate
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use